Big news for acromegaly!

September 10, 2023

San Diego, California-based Crinetics Pharmaceutical announced today that its novel investigational drug paltusotine maintained IGf-1 levels in patients who switched from monthly injectables

Helping medical students learn about acromegaly

March 2, 2023

After a few virtual meetings these past years, I was back at UC Berkeley/UCSF’s joint medical program for an in-person gathering with some of the brightest and most engaged medical students on the planet. This is, without a doubt, one of my favorite things to do since founding PWN, and I look forward to it every year.

Supporting a new diagnosis of Acromegaly

January 4, 2022

We continue to showcase Pfizer’s new series on patient support.  This brochure offers great advice on how to deal with a new acromegaly diagnosis. The materials provide valuable content given the importance of proper disease